Impact de la TEP/TDM au [68Ga]-PSMA-11 dans le ciblage thérapeutique des patients en récidive biologique d’adénocarcinome prostatique

Skanjeti, A; Dhomps, A.; Foret, T.; Sotlar, W.; Hallouard, F.; Darcissac, C.; Fraysse, M.; Tordo, J.

doi:10.1016/j.mednuc.2019.01.016

Record: found
Abstract: not found
Article: not found

Impact de la TEP/TDM au [68Ga]-PSMA-11 dans le ciblage thérapeutique des patients en récidive biologique d’adénocarcinome prostatique

Author(s): A. Skanjeti , A. Dhomps , T. Foret , W. Sotlar , F. Hallouard , C. Darcissac , M. Fraysse , J. Tordo

Publication date Created: March 2019

Publication date (Print): March 2019

Journal: Médecine Nucléaire

Publisher: Elsevier BV

Read this article at

ScienceOpenPublisher

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Title: Médecine Nucléaire

Abbreviated Title: Médecine Nucléaire

Publisher: Elsevier BV

ISSN (Print): 09281258

Publication date Created: March 2019

Publication date (Print): March 2019

Volume: 43

Issue: 2

Page: 179

Article

DOI: 10.1016/j.mednuc.2019.01.016

SO-VID: 4d1a5a30-0811-4f74-bbf4-a7ec58a9420e

License:

https://www.elsevier.com/tdm/userlicense/1.0/

History

Data availability:

Comments

Comment on this article

scite_